Repeated transfusions of genetically modified cells are required in $SCID$ patients and in enzyme replacement therapy because

  • A
    Transfused cells have a limited life span
  • B
    Introduced gene has been mutated
  • C
    The enzyme required is degraded after $20$ days of transfusion
  • D
    Both $(a)$ and $(c)$

Explore More

Similar Questions

Enzyme used in $ELISA$ test is

Hybridomas are the result of the fusion of:

Give scientific reasons: In earlier times,insulin was extracted from the pancreas of slaughtered cattle.

What is the meaning of $Bio-patents$?

Which one of the following techniques does not serve the purpose of early diagnosis of a disease for its early treatment?

Vedclass Products

For Students

Vedclass Test Series

Mock tests in real JEE/NEET style with performance analysis. 5-day free trial.

Start Free Trial
For Teachers

Exam Paper Generator

Generate Set A/B/C/D exam papers from 7.5L+ questions in 2 minutes. 3 chapters free.

Try Free
For Institutes

Online Exam Module

Live online exams with unlimited students, 360° analytics & white-label branding.

See Demo